Panacea Biotec Ltd.

Financial

	Panacea Biotec	Guj. Themis Biosyn	Gufic Biosciences
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	6.0 .	n/a	n/a
R&D as a % of Total Sales	5.51 %	n/a	0.83 %
Financials
5 yr Average ROE	17.16 %	41.95 %	25.05 %
5yr average Equity Multiplier	1.61	1.37	2.22
5yr Average Asset Turnover Ratio	0.4	0.89	1.05
5yr Avg Net Profit Margin	19.26 %	34.6 %	10.9 %
Price to Book	3.96	14.45	6.71
P/E	0.0	61.31	46.99
5yr Avg Cash Conversion Cycle	-102.87 Days	-31.8 Days	26.94 Days
Inventory Days	109.97 Days	23.52 Days	66.86 Days
Days Receivable	37.7 Days	48.29 Days	128.09 Days
Days Payable	294.14 Days	135.34 Days	163.91 Days
5yr Average Interest Coverage Ratio	2.9	187.52	13.1
5yr Avg ROCE	-1.68 %	54.74 %	27.25 %
5yr Avg Operating Profit Margin	-1.99 %	45.69 %	18.45 %
5 yr average Debt to Equity	0.05	0.05	0.51
5yr CAGR Net Profit	-64.03 %	20.11 %	14.26 %
5yr Average Return on Assets	6.95 %	30.29 %	11.52 %
Shareholdings
Promoter Holding	72.48 %	70.86 %	72.51 %
Share Pledged by Promoters	0.0	3.3 %	0.0
Change in Promoter Holding (3 Yrs)	-1.11 %	-4.13 %	-2.97 %
Change in Mutual Fund Holding (3 Yrs)	0.0	1.14 %	2.36 %

Business

	Panacea Biotec	Guj. Themis Biosyn	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Vaccines 66.33 Formulations 33.67 Research and Development 0 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Vaccines 0 Pharmaceutical 100.0 API 0 Muscle Relaxants 0 Anti-fungals 0 Cardiovascular 0 Research and Development 0 Domestic 0 Anti-bacterials 0 International 0 Formulations 0 CMO 0 Proton pump inhibitors 0	Product Wise Break-Up Vaccines 0 0 Active Pharmaceutical Ingredient (API) 5.0 Muscle Relaxants 0 Anti-fungals 0 Cardiovascular 0 Research and Development 0 Domestic Pharmaceuticals 50.0 Anti-bacterials 0 International 15.0 Formulations 0 CMO 30.0 Proton pump inhibitors 0
Therapeutic Area Wise Break-Up - Domestic	Therapeutic Area Wise Break-Up - Domestic Anti - Diabetes 43.91 Gastro Intestinal 13.47 Pain Management 12.87 Anti-Neoplastics 8.18 Vitamins / Minerals / Nutrients 6.09 Respiratory Systems 5.39 Vaccines 5.39 Blood Related 2.99 Hormones 0.6 Others 1.11	-	-
Location Wise Break-Up	Location Wise Break-Up Rest of the World 86.09 India 13.91 South America 0 Australia 0 North America 0 Europe 0 Asia 0 Africa 0	-	Location Wise Break-Up Rest of the World 0 North America 1.27 Europe 3.67 South America 0.23 India 89.07 Australia 0.53 Africa 0.72 Asia Pacific 4.5 Others 0.01
Capex	Capex Vaccines 83.1 Formulations 16.9 Real estate 0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Others 100	-	-
Brand Wise Break-Up	Brand Wise Break-Up PanGraf 21.0 Glizid Family 19.0 Sitcom Family 10.0 Mycept & Mycept 5.0 Livoluk Family 4.0 Panimun Bioral 4.0 PacliAll 1.0 Thank OD Family 0 Nimulid Family 0 Others 36.0	-	-
Asset Break-Up	Asset Break-Up Vaccines 65.28 Formulations 34.72 Real Estate 0	-	-

Panacea Biotec Ltd.

SIGN UP FOR FREE